Omit Periop Chemo in Mismatch Repair Deficient Gastric Cancer
Patients with mismatch repair deficient gastric cancer demonstrated better median overall survival when skipping perioperative chemotherapy, according to a preprint study.
First Look
source https://www.medscape.com/viewarticle/966249?src=rss
First Look
source https://www.medscape.com/viewarticle/966249?src=rss
Comments
Post a Comment